Patrick Soon-Shiong: Age, : Wealth Report Net Worth 2026: Career Earnings & Assets

Updated: May 05, 2026

  • Subject:
    Patrick Soon-Shiong: Age, Net Worth 2026: Wealth Report
  • Profile Status:
    Verified Biography
Patrick Soon-Shiong: Age,  : Wealth Report Net Worth 2026: Career Earnings & Assets

As of April 2026, Patrick Soon-Shiong: Age, is a hot topic. Specifically, Patrick Soon-Shiong: Age, Net Worth in 2026. Patrick Soon-Shiong: Age, has built a massive empire. Below is the breakdown of Patrick Soon-Shiong: Age,'s assets.

Patrick Soon-Shiong is a renowned South African-born American surgeon, medical researcher, and entrepreneur. He is best known for inventing the cancer drug Abraxane and for his significant contributions to healthcare and biotechnology. As of December 2024, his net worth is estimated at $7 billion.

Career Beginnings and Key Milestones

Soon-Shiong began his medical career focusing on diabetes treatment and transplantation. In the mid-1980s, he joined the University of California, Los Angeles (UCLA), where he developed innovative techniques for pancreatic islet cell transplantation. His groundbreaking work led to the development of Abraxane, a drug effective against various cancers, including breast, lung, and pancreatic cancer. He founded several companies, including Abraxis BioScience and NantWorks, to advance healthcare solutions.

Charitable Work and Legacy

Through the Chan Soon-Shiong Family Foundation, he supports healthcare and education initiatives. He has pledged to donate at least half of his wealth to philanthropy as part of the Giving Pledge. His work continues to impact medical research and patient care globally.

Notable Works and Achievements

The development of Abraxane marked a significant advancement in cancer treatment, offering improved outcomes for patients. Soon-Shiong’s entrepreneurial ventures, such as the founding of NantWorks, have integrated technology and healthcare to enhance patient care. His contributions have earned him recognition as one of the wealthiest doctors globally.

Early Life and Family Background

Born on July 29, 1952, in Port Elizabeth, South Africa, Patrick Soon-Shiong is the son of Chinese immigrants who fled China during World War II. His father, a village doctor, instilled in him a passion for medicine. Growing up during apartheid, Soon-Shiong experienced racial discrimination, which shaped his resilience and determination. He pursued his medical degree at the University of the Witwatersrand, graduating in 1975. He later earned a Master of Science from the University of British Columbia.

Personal Life and Relationships

Patrick Soon-Shiong is married to Michele B. Chan, a former actress. They have two children, including Nika Soon-Shiong, and reside in Los Angeles. The family is known for their philanthropic efforts, particularly in healthcare and education.

  • Full Name: Patrick Soon-Shiong
  • Date of Birth: July 29, 1952
  • Place of Birth: Port Elizabeth, Union of South Africa
  • Nationality: South African, American
  • Education: MBBCh, University of the Witwatersrand; MSc, University of British Columbia
  • Occupation: Businessman, investor, medical researcher, transplant surgeon
  • Known For: Inventor of Abraxane; developer of transplant techniques for pancreatic islets
  • Current Roles: CEO of NantWorks LLC; owner of Los Angeles Times; minority owner of Los Angeles Lakers
  • Spouse: Michele B. Chan
  • Children: 2, including Nika Soon-Shiong
  • Net Worth: $7 billion (as of December 2024)
  • Major Achievements: Development of Abraxane; advancements in cancer treatment; ownership of major media outlets

Net Worth and Lifestyle

As of December 2024, Soon-Shiong’s net worth is estimated at $7 billion. His wealth primarily stems from his pharmaceutical ventures, including the sales of Abraxis BioScience and American Pharmaceutical Partners for a combined $9.1 billion. He owns significant real estate in Los Angeles and holds a minority stake in the Los Angeles Lakers.

Current Relevance and Recent Updates

In June 2018, Soon-Shiong acquired the Los Angeles Times and The San Diego Union-Tribune, emphasizing the importance of independent journalism. He continues to focus on healthcare innovation through NantWorks and its subsidiaries, aiming to revolutionize cancer treatment and digital health.

Future Plans and Impact on Culture

Soon-Shiong aims to advance personalized medicine and digital health technologies. His influence extends into media and sports, reflecting his diverse interests and commitment to societal improvement.

Disclaimer: Patrick Soon-Shiong: Age, wealth data updated April 2026.